Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA

Journal of the American College of Cardiology

Volumn 66, Issue 21, 2015, Pages 2329-2338

  Laird, John R ^a   Schneider, Peter A ^b   Tepe, Gunnar ^c   Brodmann, Marianne ^d   Zeller, Thomas ^e   Metzger, Christopher ^f   Krishnan, Prakash ^g   Scheinert, Dierk ^h   Micari, Antonio ⁱ   Cohen, David J ^j   Wang, Hong ^k   Hasenbank, Melissa S ^k   Jaff, Michael R ^l  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAISER PERMANENTE   (United States)

^c RodMed Klinikum   (Germany)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^f Wellmont Holston Valley Medical Center   (United States)

^g MOUNT SINAI MEDICAL CENTER   (United States)

^h UNIVERSITY HOSPITAL LEIPZIG   (Germany)

ⁱ MARIA CECILIA HOSPITAL   (Italy)

^j SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^k MEDTRONIC INC   (United States)

^l MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

angioplasty; femoropopliteal artery; peripheral arterial disease; target lesion revascularization

Indexed keywords

AGED; ARTICLE; CLINICALLY DRIVEDN TARGET LESION REVASCULARIZATION; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; LEG REVASCULARIZATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY (TOPIC); PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BALLOON; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPEAT PROCEDURE; THROMBOSIS; VASCULAR PATENCY; ANGIOPLASTY; CLINICAL TRIAL; ECHOGRAPHY; INTERNATIONAL COOPERATION; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STANDARDS; TIME; TREATMENT OUTCOME; TRENDS;

PACLITAXEL;

AGED; ANGIOPLASTY; ANGIOPLASTY, BALLOON; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; PACLITAXEL; POPLITEAL ARTERY; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TIME FACTORS; TREATMENT OUTCOME;

EID: 84958961875     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.09.063     Document Type: Article

References (32)

1. L. Norgren, W.R. Hiatt, J.A. Dormandy, and et al. Inter-society consensus for the management of peripheral arterial disease (TASC II) J Vasc Surg 45 Suppl S 2007 S5 S67
2. K.J. Rocha-Singh, M.R. Jaff, T.R. Crabtree, D.A. Bloch, G. Ansel for the VIVA Physicians, Inc Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease Catheter Cardiovasc Interv 69 2007 910 919
3. M. Schillinger, S. Sabeti, C. Loewe, and et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery N Engl J Med 354 2006 1879 1888
4. P. Dick, H. Wallner, S. Sabeti, and et al. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions Catheter Cardiovasc Interv 74 2009 1090 1095
5. J.R. Laird, B.T. Katzen, D. Scheinert, and et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial Circ Cardiovasc Interv 3 2010 267 276
6. M.D. Dake, G.M. Ansel, M.R. Jaff, and et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results Circ Cardiovasc Interv 4 2011 495 504
7. M.D. Dake, G.M. Ansel, M.R. Jaff, and et al. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies J Am Coll Cardiol 61 2013 2417 2427
8. K.J. Rocha-Singh, M. Bosiers, G. Schultz, and et al. A single stent strategy in patients with lifestyle limiting claudication: 3-year results from the Durability II trial Catheter Cardiovasc Interv 86 2015 164 170
9. D. Scheinert, S. Scheinert, J. Sax, and et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting J Am Coll Cardiol 45 2005 312 315
10. O. Schlager, P. Dick, S. Sabeti, and et al. Long-segment SFA stenting - the dark sides: in-stent restenosis, clinical deterioration, and stent fractures J Endovasc Ther 12 2005 676 684
11. J.R. Laird, and K.K. Yeo The treatment of femoropopliteal in-stent restenosis: back to the future J Am Coll Cardiol 59 2012 24 25
12. G. Tepe, T. Zeller, T. Albrecht, and et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg N Engl J Med 358 2008 689 699
13. M. Werk, S. Langner, B. Reinkensmeier, and et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial Circulation 118 2008 1358 1365
14. M. Werk, T. Albrecht, D.R. Meyer, and et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial Circ Cardiovasc Interv 5 2012 831 840
15. D. Scheinert, S. Duda, T. Zeller, and et al. The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty J Am Coll Cardiol Intv 7 2014 10 19
16. H. Schroeder, D.-R. Meyer, B. Lux, and et al. Two-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: Outcomes from the ILLUMENATE first-in-human study Catheter Cardiovasc Interv 86 2015 278 286
17. K. Rosenfield, M.R. Jaff, C.J. White, and et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease N Engl J Med 373 2015 145 153
18. U. Speck, B. Cremers, B. Kelsch, and et al. Do pharmacokinetics explain persistent restenosis inhibition by a single dose of paclitaxel? Circ Cardiovasc Interv 5 2012 392 400
19. G. Tepe, J. Laird, P. Schneider, and et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial Circulation 131 2015 495 502
20. I.C. Chetter, J.I. Spark, P. Dolan, and et al. Quality of life analysis in patients with lower limb ischaemia: suggestions for European standardisation Eur J Vasc Endovasc Surg 13 1997 597 604
21. Regensteiner JG SJ, R.J. Panzer, and W.R. Hiatt Evaluation of walking impairment by questionnaire in patients with peripheral arterial disease J Vasc Med Biol 2 1990 142 152
22. M.M. McDermott, P.A. Ades, A. Dyer, and et al. Corridor-based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial disease J Vasc Surg 48 2008 1231 1237 e1
23. Jaff M. SMART Nitinol self-expanding stent in the treatment of obstructive superficial femoral artery disease: three-year clinical outcomes from the STROLL Trial. Paper presented at: International Symposium on Endovascular Therapy; January 18 to 22, 2014; Miami Beach, FL.
24. J.R. Laird, B.T. Katzen, D. Scheinert, and et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial J Endovasc Ther 19 2012 1 9
25. J.R. Laird, A. Jain, T. Zeller, and et al. Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial J Endovasc Ther 21 2014 202 212
26. A. Tosaka, Y. Soga, O. Iida, and et al. Classification and clinical impact of restenosis after femoropopliteal stenting J Am Coll Cardiol 59 2012 16 23
27. E.J. Armstrong, H. Saeed, B. Alvandi, and et al. Nitinol self-expanding stents vs. balloon angioplasty for very long femoropopliteal lesions J Endovasc Ther 21 2014 34 43
28. E.B. Jude, S.O. Oyibo, N. Chalmers, and A.J. Boulton Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome Diabetes Care 24 2001 1433 1437
29. M.S. Lee, S.W. Rha, S.K. Han, and et al. Comparison of diabetic and non-diabetic patients undergoing endovascular revascularization for peripheral arterial disease J Invasive Cardiol 27 2015 167 171
30. T. Mueller, F. Hinterreiter, C. Luft, and et al. Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes J Vasc Surg 59 2014 1291 1299
31. D.I. Axel, W. Kunert, C. Goggelmann, and et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery Circulation 96 1997 636 645
32. C. Herdeg, M. Oberhoff, A. Baumbach, and et al. Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo J Am Coll Cardiol 35 2000 1969 1976